FDA Approved Opioid Products

Abuse Deterrent Labeling

April 16, 2013:  a Reformulated Oxycontin

July 23, 2014:  New Extended-release Oxycodone

October 17, 2014:   Embeda (morphine sulfate and naltrexone hydrochloride) Extended-release (ER) Capsules.

November 20, 2014:   Hysingla ER (hydrocodone bitartrate), Extended-release, Single-entity Hydrocodone Product

FDA Approved Opioid Products Without Abuse Deterrent Labeling

October 25, 2013Zohydro ER, a Schedule II controlled substance under the Controlled Substances Act

FDA Approval Information for Opioid Products with Abuse Deterrent Labeling
Tagged on: